Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eyal Raz

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Nature Immunology|December 21, 2006
Organ-specific regulation of innate immunityEyal Raz
Seminars in Immunopathology|October 16, 2015
Transient Receptor Potential (TRP) channels in T cellsSamuel Bertin, Eyal Raz
Medecine Sciences : M/S|March 7, 2015
[A novel role for the TRPV1 ion channel in CD4 T cell activation]Samuel Bertin, Eyal Raz
The American Journal of Medicine|September 27, 2006
TLR9-based immunotherapy for allergic diseaseTomoko Hayashi, Eyal Raz
Current Opinion in Immunology|November 25, 2003
Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligandsAnthony A Horner, Eyal Raz
The Journal of Allergy and Clinical Immunology|November 6, 2002
Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseasesAnthony Adam Horner, Eyal Raz
Springer Seminars in Immunopathology|December 21, 2004
Induction of antigen cross-presentation by Toll-like receptorsSandip K Datta, Eyal Raz
Current Opinion in Molecular Therapeutics|March 9, 2002
DNA-based approaches to the treatment of allergiesHans L Spiegelberg, Eyal Raz
Annals of the New York Academy of Sciences|October 24, 2006
Homeostatic effects of TLR9 signaling in experimental colitisJongdae Lee, Daniel Rachmilewitz, Eyal Raz
Annals of the New York Academy of Sciences|January 31, 2004
The therapeutic potential of antigen-oligonucleotide conjugatesSandip K Datta, Kenji Takabayashi, Eyal Raz
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Nature Immunology|December 21, 2006
Organ-specific regulation of innate immunityEyal Raz
Seminars in Immunopathology|October 16, 2015
Transient Receptor Potential (TRP) channels in T cellsSamuel Bertin, Eyal Raz
Medecine Sciences : M/S|March 7, 2015
[A novel role for the TRPV1 ion channel in CD4 T cell activation]Samuel Bertin, Eyal Raz
The American Journal of Medicine|September 27, 2006
TLR9-based immunotherapy for allergic diseaseTomoko Hayashi, Eyal Raz
Current Opinion in Immunology|November 25, 2003
Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligandsAnthony A Horner, Eyal Raz
The Journal of Allergy and Clinical Immunology|November 6, 2002
Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseasesAnthony Adam Horner, Eyal Raz
Springer Seminars in Immunopathology|December 21, 2004
Induction of antigen cross-presentation by Toll-like receptorsSandip K Datta, Eyal Raz
Current Opinion in Molecular Therapeutics|March 9, 2002
DNA-based approaches to the treatment of allergiesHans L Spiegelberg, Eyal Raz
Annals of the New York Academy of Sciences|October 24, 2006
Homeostatic effects of TLR9 signaling in experimental colitisJongdae Lee, Daniel Rachmilewitz, Eyal Raz
Annals of the New York Academy of Sciences|January 31, 2004
The therapeutic potential of antigen-oligonucleotide conjugatesSandip K Datta, Kenji Takabayashi, Eyal Raz
Pageof 10